News & Updates

Early remdesivir treatment lowers risk of COVID-19 progression
Early remdesivir treatment lowers risk of COVID-19 progression
19 Jan 2022 byJairia Dela Cruz

In the treatment of patients with COVID-19, administering remdesivir within 5 days of symptom onset appears to reduce the risk of progression to severe disease, as shown in a study.

Early remdesivir treatment lowers risk of COVID-19 progression
19 Jan 2022